PhD (Physiology), North-West University, Potchefstroom Campus, 2015Motivation - In South Africa, various transitional changes parallel detrimental modifications in lifestyle behaviour of especially the lower socio-economic communities. We are currently double-burdened by a high prevalence of communicable and noncommunicable diseases such as diabetes, chronic respiratory and cardiovascular diseases, which is accompanied by a high cardiovascular mortality rate. Healthcare and treatment resources are limited and low-cost intervention strategies to lower this burden are urgently needed. Unhealthy lifestyle behaviours, such as excessive alcohol consumption and tobacco use, are known to augment inflammation as reflected by inflammatory markers su...
Background: Serum concentrations of soluble urokinase-type plasminogen activator receptor (suPAR) ha...
Objective and design: This cross-sectional study aimed to investigate associations between a marker ...
Soluble urokinase-type plasminogen activator receptor (suPAR) accumulates in patients with chronic k...
Background: Soluble urokinase plasminogen activator receptor (suPAR), a novel indicator of low-grade...
Thesis (M.Sc. (Physiology))--North-West University, Potchefstroom Campus, 2011.Motivation - Soluble ...
Background: Elevated inflammatory markers such as C–reactive protein (CRP) and interleukin–6 (IL–6) ...
Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker that links inflammation with...
BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) is a highly sensitive marker th...
Soluble urokinase plasminogen activator receptor (suPAR) is associated with inflammation and may pre...
Objective and design: This cross-sectional study aimed to investigate associations between a marker ...
The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality risk in var...
PhD (Physiology), North-West University, Potchefstroom CampusMotivation: Cardiovascular disease (CVD...
Inflammation is a key player in the development of an increasing amount of diseases. The soluble uro...
Thesis (PhD (Physiology))--North-West University, Potchefstroom Campus, 2012.Cardiovascular disease ...
Introduction Soluble urokinase plasminogen activator receptor (suPAR) is an emerging inflammatory an...
Background: Serum concentrations of soluble urokinase-type plasminogen activator receptor (suPAR) ha...
Objective and design: This cross-sectional study aimed to investigate associations between a marker ...
Soluble urokinase-type plasminogen activator receptor (suPAR) accumulates in patients with chronic k...
Background: Soluble urokinase plasminogen activator receptor (suPAR), a novel indicator of low-grade...
Thesis (M.Sc. (Physiology))--North-West University, Potchefstroom Campus, 2011.Motivation - Soluble ...
Background: Elevated inflammatory markers such as C–reactive protein (CRP) and interleukin–6 (IL–6) ...
Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker that links inflammation with...
BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) is a highly sensitive marker th...
Soluble urokinase plasminogen activator receptor (suPAR) is associated with inflammation and may pre...
Objective and design: This cross-sectional study aimed to investigate associations between a marker ...
The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality risk in var...
PhD (Physiology), North-West University, Potchefstroom CampusMotivation: Cardiovascular disease (CVD...
Inflammation is a key player in the development of an increasing amount of diseases. The soluble uro...
Thesis (PhD (Physiology))--North-West University, Potchefstroom Campus, 2012.Cardiovascular disease ...
Introduction Soluble urokinase plasminogen activator receptor (suPAR) is an emerging inflammatory an...
Background: Serum concentrations of soluble urokinase-type plasminogen activator receptor (suPAR) ha...
Objective and design: This cross-sectional study aimed to investigate associations between a marker ...
Soluble urokinase-type plasminogen activator receptor (suPAR) accumulates in patients with chronic k...